KatherineABurnsMD

PubMed

• 11 citations
  The Natural Estrogenic Compound Diarylheptanoid (D3): In Vitro Mechanisms of Action and in Vivo Uterine Responses via Estrogen Receptor α
  Wipawee Winuthayanon, Pawinee Piyachaturawat, Apichart Suksamrarn, Katherine A. Burns, Yukitomo Arao, Sylvia C. Hewitt, Lars C. Pedersen, Kenneth S. Korach> ;Environmental Health Perspectives. 2013 Jan 18
• 65 citations
  Selective Mutations in Estrogen Receptor α D-domain Alters Nuclear Translocation and Non-estrogen Response Element Gene Regulatory Mechanisms
  Katherine A. Burns, Yin Li, Yukitomo Arao, Robert M. Petrovich, Kenneth S. Korach> ;The Journal of Biological Chemistry. 2011 Apr 8
• 25 citations
  Insufficient Luteinizing Hormone-Induced Intracellular Signaling Disrupts Ovulation in Preovulatory Follicles Lacking Estrogen Receptor-β
  Karina F. Rodriguez, John F. Couse, Friederike L. Jayes, Katherine J. Hamilton, Katherine A. Burns, Fuminori Taniguchi, Kenneth S. Korach> ;Endocrinology. 2010 Jun 1
• 333 citations
  Modulation of PPAR activity via phosphorylation.
  Katherine A. Burns, John P. Vanden Heuvel> ;Biochimica Et Biophysica Acta. 2007 May 22
• Rotator cuff muscle architecture: implications for glenohumeral stability.
  Ward, S.R., Hentzen, E.R., Smallwood, L.H., Eastlack, R.K., Burns, K.A., Fithian, D.C., Friden, J., Lieber, R.L.> ;Clin Orthop Relat Res. 2006 Jul
• 29 citations
  Regulation of Peroxisome Proliferator-Activated Receptor α by Protein Kinase C†
  Joshua P. Gray, Katherine A. Burns, Tara L. Leas, Gary H. Perdew, John P. Vanden Heuvel> ;Biochemistry. 2005 Aug 2
• 39 citations
  Comprehensive analysis of gene expression in rat and human hepatoma cells exposed to the peroxisome proliferator WY14,643.
  John P. Vanden Heuvel, Dirk Kreder, Benjamin J. Belda, Daniel B. Hannon, Courtney A. Nugent, Katherine A. Burns, Michael J. Taylor> ;Toxicology and Applied Pharmacology. 2003 May 1
• 15 citations
  Coxa vara: another option for fixation
  Katherine A. Burns, Peter M. Stevens> ;Journal of Pediatric Orthopedics. Part B. 2001 Oct 1
• Join now to see all

Journal Articles

• Modifiable risk factors in shoulder arthroplasty increase length of stay and 90-day cost of care  
  Burns KA, *Schroer WC, Robbins LM, LeMarr AR, Morton DJ, Wilson ML, Journal of Shoulder and Elbow Surgery*, 2022
• Modifiable risk factors in shoulder arthroplasty increase length of stay and 90-day cost of care  
  Burns KA, Schroer WC, Robbins LM, LeMarr AR, Morton DJ, Wilson ML, . Journal of Shoulder and Elbow Surgery, 9/17/2021
• Healing rates and clinical outcomes after arthroscopic rotator cuff repair for patients taking either celecoxib or placebo  
  Burns KA, Robbins LM, Wilson ML, LeMarr AR, Childress AL, Morton DJ., Journal of Shoulder and Elbow Surgery International, 3/2021
• Celecoxib significantly reduces opioid use after shoulder arthroplasty: a randomized controlled trial  
  Burns KA, Schroer WC, Robbins LM, LeMarr AR, Childress AL, Burns JC, Morton DJ, Wilson ML., Journal of Shoulder and Elbow Surgery, 9/9/2020
• Predicting transfusion after shoulder arthroplasty: A retrospective cohort study.  
  Burns KA, Robbins LM, Wilson ML, LeMarr AR, Childress AL, Morton DJ., Journal of Shoulder and Elbow Surgery Open Access., 12/2019
• tator cuff repair with knotless technique is quicker and more cost effective than knotted technique  
  Burns KA, Robbins LM, LeMarr AR, Childress AL, Morton DJ, Wilson ML, Arthroscopy, Sports Medicine, and Rehabilitation, 11/29/2019
• Rotator cuff muscle architecture: implications for glenohumeral stability.  
  Ward SR, Hentzen ER, Smallwood LH, Eastlack RK, Burns KA, Fithian DC, Friden J, Lieber RL, Clin Orthop Relat Res, 2006
• Coxa vara: another option for fixation  
  Burns KA, Stevens PM, J Ped Orthop, 2001
• Join now to see all